Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 13, 2026. The Healthcare company reported…
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 13, 2026.
The Healthcare company reported Q0 revenue of .
Citius Pharmaceuticals, Inc.'s stock currently trades at $0.77 with a market capitalization of $13.0M.
Current market data
NASDAQ · CTXR
$0.59
Up: +$0.00 · +0.57%
Live quote updated
Keep reading
earnings ·
earnings ·
sec_filing ·
sec_filing ·
